Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Ovarian Epithelial × In Situ Hybridization, Fluorescence × Clear all

Sponsor

Conditions

Waldenstrom Macroglobulinemia 4 Multiple Myeloma 4 Lymphoma, Mantle-Cell 4 Lymphoma, Follicular 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Sezary Syndrome 3 Mycosis Fungoides 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Extranodal NK-T-Cell 3 Congenital Abnormalities 3 Burkitt Lymphoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Myeloproliferative Disorders 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large-Cell, Immunoblastic 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Leukemia 2 Immunoblastic Lymphadenopathy 2 Hodgkin Disease 2 Dendritic Cell Sarcoma, Interdigitating 2 Squamous Cell Carcinoma of Head and Neck 1

Interventions

Paclitaxel 21 Carboplatin 16 liposomal doxorubicin 12 Bevacizumab 8 Topotecan 7 Docetaxel 7 Cisplatin 7 pembrolizumab 6 rucaparib 5 mirvetuximab soravtansine 5 Gemcitabine 5 Cyclophosphamide 5 Taxes 4 Albumin-Bound Paclitaxel 4 sargramostim 3 ixabepilone 3 Cytoreduction Surgical Procedures 3 130-nm albumin-bound paclitaxel 3 taxane 2 talazoparib 2 pazopanib 2 fludarabine phosphate 2 fludarabine 2 denileukin diftitox 2 cediranib 2 catumaxomab 2 belinostat 2 avelumab 2 aflibercept 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡